Does PDUFA Need A Haircut? FDA Ponders Trimming Its Responsibilities
This article was originally published in The Pink Sheet Daily
Executive Summary
Acting Commissioner Ostroff wonders if all aspects of user fee program are delivering maximum added value.
You may also be interested in...
PDUFA VII Talks To Begin With COVID-19, Other Familiar Issues To Consider
US FDA staffing problems and patient engagement enhancements will be listed as priorities during reauthorization kick-off meeting.
US FDA's Ostroff, Twice An Acting Commissioner, Retiring Next Year
A former Walmart executive will replace the deputy commissioner for foods and veterinary medicine, who spent nearly 15 months total as acting commissioner.
Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post
Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.